Service

Oxford Immunotec Ltd.

94C Innovation Drive, Milton Park , OX14 4RZ Abingdon, Oxfordshire
United Kingdom

Telephone +44 1235 442780
Fax +44 1235 442781
info@oxfordimmunotec.com

This company is co-exhibitor of
The Gambica Association Limited

Trade fair hall

  • Hall 1 / E10
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 1): stand E10

Fairground map

MEDICA 2016 fairground map: Hall 1

Our range of products

Product categories

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems

Immuno assay systems

Our products

Product category: Immuno assay systems

T-SPOT®.CMV

The T-SPOT®.CMV test is available now as a CE-marked kit in the EU, and will soon be available in the UK as a testing service from our UK Oxford Diagnostic Laboratories.

T cell immunity against CMV is a factor in controlling viral latency and susceptibility to CMV disease. CMV can affect individuals with weaknesses in their T cell response and it is therefore an important and common cause of morbidity and mortality in solid organ and hematopoietic stem cell transplant recipients. The T-SPOT.CMV test measures the strength of T cell responses to CMV specific antigens. The T-SPOT.CMV test has the potential to assist clinicians with monitoring anti-viral prophylaxis and evaluating patients at risk from CMV disease.

More Less

About us

Company details

Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. Our proprietary T-SPOT® technology platform allows us to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases.

Our first product is the T-SPOT.TB test, which is used to test for tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The T-SPOT.CMV test is the Company’s second product and the first in a series of products intended for the transplantation market. Overall, Oxford Immunotec has several active development programs, each of which leverages our T cell, B cell and innate immune measuring technology. We are headquartered near Oxford, UK and in Marlborough, Mass.

Additional information can be found at www.oxfordimmunotec.com.

More Less

Company data

Sales volume

10-49 Mio US $

Export content

max. 75%

Number of employees

100-499

Foundation

2002

Area of business

Diagnostics